PMID: 7546907Jul 1, 1995Paper

Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism

AIDS Research and Human Retroviruses
B JacobssonS Eriksson

Abstract

Azidothymidine (zidovudine, AZT) used for treatment of HIV infection blocks the viral reverse transcriptase after phosphorylation by cellular enzymes. The first step in this reaction is the formation of AZT monophosphate, primarily catalyzed by host cytoplasmatic thymidine kinase (TK1). The activity of TK1 was determined in extracts of PHA-stimulated peripheral blood mononuclear cells (PBMCs) from 20 healthy volunteers and 49 HIV-infected patients at different stages of disease. In both groups we found a large intra- and interindividual variation of TK activity. Because TK1 expression is cell cycle regulated the proportion of stimulated cells was determined in the samples and the median thymidine kinase activity calculated. It was 3.0 pmol/mg/min x % S phase in the HIV-seronegative group and 1.1 pmol/mg/min x % S phase in HIV-infected individuals. The difference in thymidine kinase activity is statistically significant (p = 0.0001). The concentration of TK1 protein in the same extracts was also determined by immunoblotting. A positive correlation (r = 0.74) was observed between TK activity and amount of TK1 protein. The reason for this downregulation of TK is still unknown but may be related to the anergy observed in lymphocyte...Continue Reading

References

Sep 1, 1991·AIDS Research and Human Retroviruses·Y TörnevikS Eriksson
Sep 1, 1991·AIDS Research and Human Retroviruses·J P JohnsonR Shinaberry
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P A FurmanH Mitsuya
Feb 4, 1987·Nature·H Mitsuya, S Broder

❮ Previous
Next ❯

Citations

Nov 30, 2002·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·B Macchi, A Mastino
Jan 29, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ofelia A OliveroMiriam C Poirier
Dec 30, 2009·Antimicrobial Agents and Chemotherapy·Selwyn J HurwitzRaymond F Schinazi
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Elijah PaintsilYung-Chi Cheng
Dec 25, 2012·Antimicrobial Agents and Chemotherapy·Christina GavegnanoRaymond F Schinazi
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·P G HoggardD J Back
Oct 7, 2003·Annals of Surgical Oncology·Tommy BrownDominique Broccoli
Oct 12, 2001·Current Medical Research and Opinion·E Papadopulos-EleopulosT Miller
Mar 30, 2002·Alcoholism, Clinical and Experimental Research·Om PrakashSteve Nelson
Apr 5, 2013·Drug Discovery Today. Technologies·Selwyn J Hurwitz, Raymond F Schinazi
Aug 31, 2011·Antiviral Research·Selwyn J Hurwitz, Raymond F Schinazi
Oct 4, 2000·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K Mokbel
Oct 30, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·N Chantal PeltenburgAnnelies Verbon
Jan 6, 2006·Environmental and Molecular Mutagenesis·Ofelia A Olivero
Jun 28, 2006·IUBMB Life·David C Samuels
Mar 27, 2004·Nucleosides, Nucleotides & Nucleic Acids·Jisook KimCarston R Wagner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.